CN1117731A - 具有抑制精神病活性的芳香杂环化合物 - Google Patents

具有抑制精神病活性的芳香杂环化合物 Download PDF

Info

Publication number
CN1117731A
CN1117731A CN94191142A CN94191142A CN1117731A CN 1117731 A CN1117731 A CN 1117731A CN 94191142 A CN94191142 A CN 94191142A CN 94191142 A CN94191142 A CN 94191142A CN 1117731 A CN1117731 A CN 1117731A
Authority
CN
China
Prior art keywords
compound
benzisothiazole
butyl
piperazinyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94191142A
Other languages
English (en)
Chinese (zh)
Inventor
M·H·诺曼
F·纳瓦斯三世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of CN1117731A publication Critical patent/CN1117731A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN94191142A 1993-02-10 1994-02-10 具有抑制精神病活性的芳香杂环化合物 Pending CN1117731A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9302622.7 1993-02-10
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Publications (1)

Publication Number Publication Date
CN1117731A true CN1117731A (zh) 1996-02-28

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191142A Pending CN1117731A (zh) 1993-02-10 1994-02-10 具有抑制精神病活性的芳香杂环化合物

Country Status (15)

Country Link
EP (1) EP0683778A1 (ja)
JP (1) JPH08506337A (ja)
CN (1) CN1117731A (ja)
AU (1) AU6005194A (ja)
BG (1) BG99839A (ja)
CA (1) CA2155758A1 (ja)
CZ (1) CZ204495A3 (ja)
FI (1) FI953777A (ja)
GB (1) GB9302622D0 (ja)
HU (1) HUT73654A (ja)
IL (1) IL108601A0 (ja)
MX (1) MX9401080A (ja)
SK (1) SK99195A3 (ja)
WO (1) WO1994018196A1 (ja)
ZA (1) ZA94891B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002039988A2 (en) * 2000-11-14 2002-05-23 Merck Patent Gmbh Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
WO2002066469A2 (en) * 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
ES2280602T3 (es) 2001-07-26 2007-09-16 Merck Patent Gmbh Uso de 2-(5-(4-fluorofenil)-3-piridilmetilaminometil)-cromano y sus sales fisiologicamente aceptables.
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
AU2005263592A1 (en) * 2004-07-20 2006-01-26 Siena Biotech S.P.A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
EP2736905A4 (en) * 2011-07-28 2015-07-29 Mapi Pharma Ltd INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
HUT73654A (en) 1996-09-30
CA2155758A1 (en) 1994-08-18
WO1994018196A1 (en) 1994-08-18
CZ204495A3 (en) 1996-03-13
EP0683778A1 (en) 1995-11-29
SK99195A3 (en) 1995-12-06
FI953777A0 (fi) 1995-08-09
HU9501881D0 (en) 1995-08-28
JPH08506337A (ja) 1996-07-09
GB9302622D0 (en) 1993-03-24
BG99839A (bg) 1996-02-28
IL108601A0 (en) 1994-05-30
AU6005194A (en) 1994-08-29
ZA94891B (en) 1995-08-10
MX9401080A (es) 1994-08-31
FI953777A (fi) 1995-08-09

Similar Documents

Publication Publication Date Title
CN1308327C (zh) 咪唑并吡啶衍生物
CN1186324C (zh) 稠合杂芳基衍生物
CN1051767C (zh) 作为hiv逆转录酶抑制剂的苯并噁嗪酮
CN1662496A (zh) 大麻素受体激动剂
CN1117731A (zh) 具有抑制精神病活性的芳香杂环化合物
CN1141043A (zh) 非肽类速激肽受体拮抗剂
CN1055925A (zh) 吡啶衍生物及其制备方法
CN1805938A (zh) 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
CN1045781A (zh) N-(3-羟基-4-哌啶基)(二氢苯并呋喃，二氢-2h-苯并吡喃或二氢苯并二英)甲酰胺衍生物
CN1040755C (zh) 杂环化合物的制备方法
CN1835944A (zh) 作为ccr－5拮抗剂的喹啉酰胺衍生物
CN1871244A (zh) 作为腺苷受体配体的噻唑并吡啶衍生物
CN1653067A (zh) 咔唑衍生物及其作为神经肽y5受体拮抗剂的应用
CN1871242A (zh) 作为mch r1拮抗剂用于治疗肥胖症、糖尿病、抑郁症和焦虑的3－(4－(氨基苯基)噻吩并嘧啶－4－酮衍生物
CN1802375A (zh) 用于治疗炎性疾病的β－咔啉
CN1268949A (zh) 稠合噻吩化合物及其医药用途
CN1798744A (zh) 作为nmda/nr2b拮抗剂的3－氟－哌啶化合物
CN1303384A (zh) 吡咯并[1,2－a]吡嗪sPLA2抑制剂
CN1020900C (zh) 制备新的取代n-(3-羟基-4-哌啶基)苯甲酰胺的方法
CN1153766C (zh) 新的硝酮化合物，其制备方法以及含有它们的药物组合物
CN1897941A (zh) 趋化因子受体活性的烷基氨基、芳基氨基以及氨磺酰基环戊基酰胺调节剂
CN1309653A (zh) 多环噻唑烷－2－亚基胺、其制备方法和作为药物的用途
CN1179962C (zh) 氮杂吲哚嗪酮衍生物和以其为有效成分的脑功能改善剂
CN1085550A (zh) 作为人类免疫缺乏病毒逆转录酶抑制剂的新的喹唑啉类
CN1017901B (zh) 抗精神病药稠环吡啶基哌嗪衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication